Alejandro J. Loyola-Velez

Internal Medicine
Isabela, PR 00662

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.

SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.

Journal: Digestive diseases and sciences
Published: October 17, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026